Dr J R Hobbs (RoyalPostgraduate Medical School, London) Immunoglobulins and Malabsorption Of the five known classes of immunoglobulins, yA-globulin is the class most directly related to the humoral defence of the gut. It exists in the serum in a 7S form (mol.wt. 160,000) but is found in the secretions in an 11S form (mol.wt. 380,000) now known as secretory yA-globulin. The relationship between the serum and secretory forms are still under investigation. Secretory yA-globulin and the Gut Concurrently with the observations of Tomasi et al. (1965) on the presence of an llS secretory yA-globulin in colostrum and saliva, Crabbe et al. (1965) showed that 85 % of the plasma cells of the lamina propria of the small intestine produced yA-globulin. Lipton & Steigman (1963) described the coproantibodies to polioviruses, and Kono et al. (1966) confirmed that these were immunoglobulins, yet showed that unlike yM-globulin they were resistant to trypsin and mercaptoethanol. Adinolfi et al. (1966) showed that 1iS secretory yA-antibodies could fix complement and together with lysozyme were very effective in destroying bacteria, whereas the 7S yA-antibodies in the serum could not fix complement or lyse bacteria. Thus was described a defence mechanism which could protect the human gut. Dr A Douglas and I have been able to measure levels of llS yA-globulin of 15-50 mg/100 ml in human jejunal juice.
It is now believed that the plasma cells of the lamina propria locally release 7S yA-globulin (mol.wt. 160,000) which is taken up by the epithelial cells lining the gut. Two 7S molecules are dimerized and combined with a non-immunoglobulin glycoprotein T-piece of molecular weight 60,000, which is synthesized within the epithelial cells. This probably protects the 11S molecule of secretory yA-globulin (mol.wt. 380,000) from tryptic digestion or reduction, e.g. by mercaptoethanol. It seems the 1 1 S molecule is only secreted one way into the lumen of the gut, for it has not been detected in serum or chyle.
It is known that complement is fixed by the Fc portion of the 7S yG-globulin molecule. 19S yMglobulin has 5 Fc portions in a single molecule and is some 3,000-7,000 times more efficient than 7S yG-globulin at fixing complement and lysing cells; this is believed to result because two Fc portions have to be close together to facilitate complement activation of the esterase which can form a hole in the cell membrane and result in lysis. Some 7,000 yG molecules have to become fixed to a single red blood cell to yield an average chance for this event, whereas a single molecule of yM seems adequate as it has 5 Fc portions in one place. The 1 IS dimer of secretory yA-globulin has two Fc portions in one place and this may explain its ability to fix complement, which is not found for 7S yA-globulin with only one Fc portion.
Whether or not serum 7S yA-globulin can contribute to the local pool taken into the epithelial cells is still an open question. Butler et al. (1967) prepared radioisotope-labelled 7S and llS yA-globulin; after intravenous administration neither appeared in the 11S fraction of secretions. On the other hand South et al. (1966) gave 7S yA-globulin intravenously to 5 hypogammaglobulinamic children who previously had no detectable yA-globulins. They claimed that yA-globulin appeared in the saliva of 3 of them.
It is still unknown to what extent the local pool can contribute to the serum 7S yA-globulin level, though the evidence below suggests that it does.
Indirect evidence that some exchange is likely is the correlation between the serum content and the fical content of antibodies against polioviruses (Lipton & Steigman 1963) . Further evidence is the demonstration by Tokumaru (1966) that of the three major serum immunoglobulins (yG, yM, yA) it was the antibody content in the serum yA-globulin that correlated best with protection against herpes simplex of the mucus surfaces.
Raised Serum yA-globulin Levels with Malabsorption From the above it seems that the serum levels of immunoglobulins in malabsorption states are a poor window on to what is happening in the gut. Nevertheless Table 1 shows that a yA level above the 2 S.D. limit of normal (425 mg/100 ml or 172 % of the adult mean) was found in some 20 % of 227 patients. This was especially the case for diseases actively involving the wall of the small gut, e.g. Crohn's, Whipple's. In one patient operated on for Crohn's disease the yA-level in the portal venous plasma was 30% higher than in the simultaneously sampled cubital venous plasma. This strongly suggests that locally made yA-globulin can contribute to the serum level. It can also be seen that in half of all the patients studied the serum immunoglobulin levels were within normal limits. These studies were made in co-operation with Professor C C Booth's team at Hammersmith.
Immunoglobulin Deficiencies Predisposing to Malabsorption
Four types of immunoglobulin deficiency seem to predispose to malabsorption states: (I) Severe hypogammaglobulinwmia, congenital or acquired, in which there is usually an all-round deficiency of yG, yA, and yM-globulins with serum levels all below 20% of the mean adult normal levels (in mg/100 ml <200 yG, <50 yA, <20 yM). Diarrhoea, sprue-like syndromes and malabsorption occurred in 20-50% of American series (e.g. Good et al. 1962) . The incidence of steatorrhoea in the MRC series of 176 patients (1969) was much lower; indeed, gastrointestinal disorders were only recorded in 14%. In an adult who acquired severe hypogammaglobulinwmia secondary to chronic lymphatic leukaemia Binder & Reynolds (1967) reported a steatorrhcea which did not respond to treatment with y-globulin (largely yG), yet which did respond to therapy with fresh plasma that also contained yA. Gryboski et al. (1968) also record a patient with yA deficiency where plasma was able to correct diarrhoea of thirteen years' standing. These 2 patients indeed suggest that serum yA-globulin can contribute to the defence of the gut, and that yA-deficiency can be the dominant cause of gut symptoms. In severe hypogammaglobuliniemia jejunal biopsy usually shows normal villi, although partial or total atrophy has been recorded: when present this has not usually responded to a gluten-free diet. Finally where hypogammaglobulinxemia is part of a combined cellular and humoral deficiency state (Hitzig 1968 ), diarrhoea, malabsorption and failure to thrive is the rule and most affected infants die within six months of birth.
(2) Dysgammaglobulinwemia Type I (Giedion & Scheidegger 1957) in which serum levels of yA and yM are undetectable or very low, less than 10% of the mean adult normal, and those of yG are usually borderline (300-500 mg/100 ml). This is nearly always genetic in origin. Hermans et al. (1966) described 8 such patients who all had diarrhoea, with stools containing Giardia lamblia, and nodular lymphoid hyperplasia demonstrable radiologically or by jejunal biopsy. Several further cases are now recorded, but these patients seem to represent one type of presentation for such milder antibody deficiency syndromes. Nodular lymphoid hyperplasia does not occur in all cases and is not specific to Type I, being now recorded with Type IV dysgammaglobulinmmia (Gryboski et al. 1968 ).
(3) Dysgammaglobulinwemia Type IV in which there is a genetic isolated deficiency of yAglobulin in both serum and secretions. Cattan et al. (1966) first emphasized an association with malabsorption, and symptoms thereof are recorded in 12 of 75 such patients (Hobbs 1968a) . A few patients are symptomless, yet some of these can show total villous atrophy on jejunal biopsy. In those with gut symptoms some show a normal biopsy, some show the clinical picture of tropical sprue (Jarnum et al. 1968 ) while others may show a flat biopsy which may respond to a glutenfree diet (Crabbe & Heremans 1967) or, as in the case of Cattan et al. (1966) , to antibiotics only. The yA deficiency is permanent and refractory to such treatments and presumably precedes any gut changes. In the patient of Gryboski et al. (1968) , correction of the yA deficiency by plasma infusion corrected the gut disorder. The associations are undeniable, but no simple or single mechanism explains why the clinical patterns vary from healthy normal, through antibiotic or glutensensitive to refractory enteropathies.
(4) Dysgammaglobulinwmia Type V, a genetic isolated deficiency of yM-globulin (Hobbs et al. 1967 ) on which our evidence is preliminary. One patient of Dr J Paulley's with malabsorption and yM deficiency, and infested with an unidentified histoplasma-like organism, shows normal jejunal villi and no lymphoid nodules. Another patient with yM deficiency has Whipple's disease. It may be that in these cases the yM deficiency has enabled unusual organisms to become established in the gut, resulting in malabsorption. Both patients are responding to antibiotics.
Malabsorption Predisposing to
Immunoglobulin Deficiency Severe protein loss as in intestinal lymphangiectasia (Strober et al. 1967) or Menetriere's hypertrophic gastritis results in an increased turnover of the immunoglobulins. Because yG normally enjoys a long half-life (twenty-four days) it suffers most and the serum levels become subnormal (<550 mg/100 ml). However, because the yG is usually of good quality the patients suffer little excess infection even though levels of 100 mg/100 ml are not uncommon. Since yA and yM normally have short half-lives (5-7 days) they are not usually reduced below the 2 S.D. lower limit of normal (c. 50% mean adult normal). This immunoglobulin patternsubnormal yG with normal yA and yMis therefore easily distinguished from the others. In my experience (Hobbs 1968b ) of other causes of catabolic hypogammaglobulinmmia such as the nephrotic syndrome it does not cause malabsorption per se.
Immunoglobulins in Idiopathic Steatorrhma
Raised serum levels of yA-globulin (in 15 %) and the yA deficiency (in 5 %) have been found among 96 patients with gluten-sensitive total villous atrophy, and have already been considered. Hobbs & Hepner (1968) reported subnormal serum levels of yM-globulin in 40% of patients, especially in those not treated; this was confirmed by Blecher et al. (1969) . This systemic yM deficiency appears to be acquired by a depression of the total daily yM synthesis (Brown et al. 1969 ) despite the fact that in the jejunal mucosa there is an increase in local numbers of yMproducing plasma cells . Such a local increase in yM production in secretions is seen in patients with inborn yA deficiency, probably as a local compensation. It may be that the secretory yA of the jejunum of cceliac patients is of inferior quality, and that local yM production increases in a compensatory manner.
Yet untreated cceliac disease seems to inhibit distant yM synthesis and also lymphocyte transformation (Holt et al. 1969 , Blecher et al. 1969 ).
These two measurable effects may presage the general lymphoreticular dysfunction (McCarthy et al. 1966 ) and local neoplastic lymphadenopathy (Whitehead 1968 ) which complicate longstanding idiopathic steatorrhoea.
The serum levels of yG and yD-globulins are unremarkable in coeliac disease but, in cooperation with Dr S G 0 Johansson, we have shown that 6% of patients have a high serum level of yE-globulin, a finding typical of reaginic allergy. This seems unrelated to gluten in that no significant difference is seen between patients before and after commencing a gluten-free diet, and some other reaginic allergy such as allergic rhinitis has been detected in some patients. Lymphomata and Malabsorption Three types of lymphoma are associated with malabsorption and serum immunoglobulin measurements reveal a subnormal level of yMglobulin in over 80 % of cases.. et al. (1967) have reported lymphoma primarily of the small gut in some 7 % of patients with coeliac disease, mainly in the longstanding cases known to have had cceliac symptoms for some twenty years. Most often these tumours resemble reticulosarcoma, yet 6 cceliac cases studied have all had subnormal yM. This contrasts with 20 other reticulosarcomata which were usually fatal before much immune deficiency could develop; only 6 had subnormal yM before death (Hobbs 1968b) .
Harris
Occasionally the small gut becomes involved with widespread lymphomatosis which has begun elsewhere, and 3 such cases of Hodgkin's disease have been encountered. In these patients malabsorption has been a terminal complication.
Recently Seligmann et al. (1968) have found a most unusual immunoglobulin in Arabian lymphoma of the small gut and we have confirmed their findings in a further patient referred to Dr Avery Jones. This disease usually presents in late adolescence as intractable malabsorption. It is confined to patients of Arabian stock, it affects both sexes, and results in a pipe-like involvement of the whole of the wall of the small gut by a plasma cell neoplasia. Studies have revealed a large excess of the a-chain of yA-globulin without any light chains, and a profound depression of all normal immunoglobulins. No Bence-Jones proteinuria occurs and little of the serum a-chain is excreted as it is highly polymerized in the serum. So far all cases have belonged to the Le subclass of a-chains and this further supports the genetic origin of a disease which may well affect only the secretory yA plasma cells of the small gut. It is striking that this genetic disorder of yAglobulin synthesis is confined to the small intestine, for salivary and rectal yA is normal in these patients. This is unlike most inborn metabolic errors which are generalized.
Conclusions
Studies of the immunoglobulins in serum and secretions indicate an important role of yAglobulin in the humoral defence of the gut. Serum levels tend to rise with diseases of the gut and deficiency of yA-globulin can predispose to malabsorption states. An excess of Le type achains in young Arabs is specifically associated with neoplasia of the small gut yA plasma cells.
There may be strictly regional disorders of secretory yA-metabolism.
Deficiency of yM-globulin may predispose to unusual infections of the gut but is more often secondary to untreated coeliac disease and may presage or be found with lymphoma.
Professor Sam Shuster and Dr Janet Marks (University Department ofDermatology, Royal Victoria Infirmary, Newcastle upon Tyne)
Dermatitis Herpetiformis and the Celiac Syndrome
The relationship between dermatitis herpetiformis and the coeliac syndrome is best understood if we consider the four ways in which skin disease and malabsorption are related. Theso are: (1) Malabsorption causes skin disease as in the coeliac syndrome and sprue. (2) Skin disease causes malabsorption as in dermatogenic enteropathy (Shustcr & Marks 1965) . (3) The skin and the bowel are involved by the same disorder as in the polysystem diseases such as periarteritis. (4) The skin and the small bowel are indirectly related, i.e. not through (1), (2) or (3); dermatitis herpetiformis falls into this group.
Our demonstration of an enteropathy in dermatitis herpetiformis (Marks et al. 1966 ) was confirmed by van Tongeren et al. (1967) and by a number of other workers (Fraser et al. 1967 , Fry et al. 1967 , Marks et al. 1968 ). The nature of this enteropathy has since been more clearly defined (Shuster et al. 1968 ). We have now studied some 30 patients with the dermatosis and in two-thirds of these there is a significant enteropathy (Marks & Shuster 1969) . The stereomicroscopic appearances of the jejunal mucosa are equally divided between partial villous atrophy with a flat mosaic appearance and convolutions. The stereomicroscopic and histological studies have revealed no differences between the enteropathy of dermatitis herpetiformis and the cceliac syndrome. The biochemical findings include malabsorption of fat, folate d-xylose, iron and occasionally vitamin B12. We have not found radiological features of osteomalacia but there is no reason why this too should not occur. A few of our patients have had lactose intolerance in keeping with the findings of Fraser et al. (1967) . The clinical features are usually milder than in classical coeliac syndrome although they may be equally severe (Marks & Shuster, unpublished observations). The probable reason for this is that patients with more severe abnormalities or with symptoms would have been referred for gastrointestinal investigations at an earlier date, and of course patients with the coeliac syndrome may have gross bowel changes with little in the way of symptoms.
What other evidence is there that the coeliac syndrome forms part of the enteropathy of dermatitis herpetiformis? The structural abnormality in the bowel is very suggestive of a hypersensitivity to a dietary constituent in that the changes are less marked in biopsies taken progressively lower down the small bowel; the proximal jejunal mucosa may be quite flat whilst the distal jejunum and terminal ileum may be perfectly normal. Evidence that the external dietary factor may sometimes be associated with gluten has been obtained in a number of patients (van Tongeren et al. 1967 , Fry et al. 1967 , Marks et al. 1968 , Shuster et al. 1968 ). We have shown such an association, first, by demonstrating a subacute focal reaction to gluten instilled into the bowel and, secondly, by finding a clinical and histopathological improvement in the small bowel mutcosa following a gluten-free diet. To date, too
